UPDATE 1-Wyeth’s Pristiq hit by FDA heart, liver concerns (Depression News)
Reuters - It is one of Wyeth’s most important experimental products and is also awaiting approval as a depression treatment. The company is counting on Pristiq, a derivative of Wyeth’s $3.5-billion-a-year Effexor antidepressant, to offset expected plunging Read more
Forbes - Eli Lilly’s second-quarter sales rose by 20 pct, driven by increased sales of its depression treatment Cymbalta and its diabetes drug Byetta. Here Eli Lilly competes with Lundbeck and Novo Nordisk respectively, said dealers. They added that the Danish Read more
Dallas Observer - In the last decade, she’d been through three miscarriages and two live births; after each she’d slipped into post-partum depression. Treatment with Zoloft had helped, but Dena would stop taking it when she felt better Read more
Seattle Post Intelligencer - Patients and parents concerned about the safety of antidepressant medications will find some reassurance in the latest research. Our Group Health research team recently found the risk of suicide attempts declines after starting depression treatment Read more
